Effect of supplementation in treatment of women with gestational diabetes
Phase 3
- Conditions
- Gestational diabetes.Diabetes mellitus in pregnancy, unspecifiedE28.2
- Registration Number
- IRCT201704225623N109
- Lead Sponsor
- Vice chancellor for research, Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Pregnant women aged 18-40 years
Diagnosed with GDM at 24-28 weeks' gestation
Exclusion Criteria
History of placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Kidney or liver diseases
Taking magnesium, zinc, calcium and vitamin D supplements prior to intervention
Being smoker
Insulin therapy after GDM diagnosis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hs-CRP. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: ELISA kit.;Total nitrite. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.
- Secondary Outcome Measures
Name Time Method